PL411078A1 - Complex silver compound, method for producing a complex compound and application of a complex compound - Google Patents

Complex silver compound, method for producing a complex compound and application of a complex compound

Info

Publication number
PL411078A1
PL411078A1 PL411078A PL41107815A PL411078A1 PL 411078 A1 PL411078 A1 PL 411078A1 PL 411078 A PL411078 A PL 411078A PL 41107815 A PL41107815 A PL 41107815A PL 411078 A1 PL411078 A1 PL 411078A1
Authority
PL
Poland
Prior art keywords
compound
complex
silver
metronidazole
producing
Prior art date
Application number
PL411078A
Other languages
Polish (pl)
Inventor
Justyn Ochocki
Urszula Kalinowska-Lis
Original Assignee
Uniwersytet Medyczny w Łodzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny w Łodzi filed Critical Uniwersytet Medyczny w Łodzi
Priority to PL411078A priority Critical patent/PL411078A1/en
Priority to PCT/EP2016/051710 priority patent/WO2016120332A1/en
Publication of PL411078A1 publication Critical patent/PL411078A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Wynalazek dotyczy związku kompleksowego srebra i metronidazolu, sposobu wytwarzania tego związku, oraz zastosowania związku do wytwarzania preparatu do hamowania rozwoju mikroorganizmów chorobotwórczych, w profilaktyce lub leczeniu zwierzęcia lub człowieka. W sposobie wytwarzania związku kompleksowego srebra i metronidazolu, stosuje się jako reagenty metronidazol i związek srebra(I), który to związek srebra(I) jest co najmniej częściowo rozpuszczalny w środowisku reakcyjnym. Reagenty zestawia się w środowisku reakcyjnym zawierającym rozpuszczalnik hydroksylowy w temperaturze 5 - 90°C, i prowadzi się reakcję przez 1 - 180 minut utrzymując temperaturę 5 - 90°C ewentualnie pobudzając mechanicznie środowisko reakcyjne, a następnie wydziela się związek kompleksowy srebra i metronidazolu.The invention relates to a complex compound of silver and metronidazole, a method for preparing this compound, and the use of a compound for the preparation of a preparation for inhibiting the development of pathogenic microorganisms, in the prevention or treatment of an animal or human. In the process for producing the silver compound and metronidazole, metronidazole and a silver (I) compound are used as reactants, which silver (I) compound is at least partially soluble in the reaction medium. The reactants are combined in a reaction medium containing a hydroxyl solvent at a temperature of 5 - 90 ° C, and the reaction is carried out for 1 - 180 minutes, maintaining the temperature at 5 - 90 ° C, optionally mechanically stimulating the reaction environment, and then the silver and metronidazole complex compound is isolated.

PL411078A 2015-01-27 2015-01-27 Complex silver compound, method for producing a complex compound and application of a complex compound PL411078A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL411078A PL411078A1 (en) 2015-01-27 2015-01-27 Complex silver compound, method for producing a complex compound and application of a complex compound
PCT/EP2016/051710 WO2016120332A1 (en) 2015-01-27 2016-01-27 Silver complex compound, the method of preparation of the complex compound and the use of the complex compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL411078A PL411078A1 (en) 2015-01-27 2015-01-27 Complex silver compound, method for producing a complex compound and application of a complex compound

Publications (1)

Publication Number Publication Date
PL411078A1 true PL411078A1 (en) 2016-08-01

Family

ID=55236377

Family Applications (1)

Application Number Title Priority Date Filing Date
PL411078A PL411078A1 (en) 2015-01-27 2015-01-27 Complex silver compound, method for producing a complex compound and application of a complex compound

Country Status (2)

Country Link
PL (1) PL411078A1 (en)
WO (1) WO2016120332A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
WO1997002038A1 (en) 1995-06-30 1997-01-23 Capelli Christopher C Silver-based pharmaceutical compositions
US6093414A (en) * 1997-08-11 2000-07-25 Christopher C. Capelli Silver-based antimicrobial compositions
WO1998006260A1 (en) * 1996-08-16 1998-02-19 Capelli Christopher C Silver-based antimicrobial compositions
CN102688258A (en) * 2012-06-16 2012-09-26 李泽红 Medicine for external use for treating psoriasis, leucoderma, fungus infection and bromhidrosis
PL404583A1 (en) * 2013-07-08 2015-01-19 Uniwersytet Medyczny w Łodzi A silver complex compound, a method for producing the compound, and the use of the compound

Also Published As

Publication number Publication date
WO2016120332A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
PH12020550901A1 (en) Macrocyclic compounds for treating disease
MX2018015853A (en) Multispecific antibodies against cd40 and cd137.
MX2020000387A (en) General and direct method for preparing oligonucleotide-functiona lized metal-organic framework nanoparticles.
MX2019009861A (en) Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof.
MX2022014914A (en) Glycan-interacting compounds and methods of use.
MX2020001757A (en) Compounds, salts thereof and methods for treatment of diseases.
MX2018015892A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2018014849A (en) Adenosine derivatives for use in the treatment of cancer.
MX2017016325A (en) Brk inhibitory compound.
PH12015502414A1 (en) Enhancer of zeste homolog 2 inhibitors
PL412787A1 (en) Macrophage-based aimed system for delivery of ferritin related compounds
EA201891526A3 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
CY1124387T1 (en) METHOD FOR PRODUCING A NEW NITROGEN-CONTAINING CHEMICAL COMPOUND OR SALT THEREOF, AND PRODUCING AN INTERMEDIATE THEREOF
MX2020006237A (en) Compounds for treatment of diseases related to dux4 expression.
MX2019008808A (en) Pyrimidine compound and pharmaceutical use thereof.
PH12021550382A1 (en) Tetrahydropyridopyrimidine derivatives as ahr modulators
PH12018502337A1 (en) Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions
PH12018502314A1 (en) Enhancer of zeste homolog 2 inhibitors
CR20210294A (en) Heteroaromatic compounds as vanin inhibitors
JOP20210034A1 (en) Heteroaromatic compounds as vanin inhibitors
EA201790604A1 (en) Inhibitors of histonedehylase
WO2019036417A3 (en) Inhibition of ngly1 for the treatment of cancer
EA201992196A1 (en) METHOD FOR SYNTHESIS OF ZEOLITE CRYSTALS WITH AN EXTENDING AGENT
UA117524C2 (en) Plant stimulators, use thereof and method of plant stimulation
PL411078A1 (en) Complex silver compound, method for producing a complex compound and application of a complex compound